Companies making popular weight loss drugs, including Ozempic and Wegovy, will be required to add a warning label about a rare eye condition that can cause blindness, the US Food and Drug Administration (FDA) has said.
Similar stories
5 outlets
See how this story developed, hour by hour
Pharmaceutical firms focus on weight-loss drugs could put insulin supply at risk, experts warn
theguardian.com
10.11.2026
The Next Generation of Weight-Loss Drugs Is Reshaping People’s Looks—And Not in a Flattering Way
menshealth.com
12.11.2026
Popular GLP-1 Weight Loss Drugs Linked to Potential Effects on Brain Health
newsweek.com
10.11.2026
FDA Orders New Vision Loss Warning for Ozempic, Wegovy, Mounjaro and Zepbound
mensjournal.com
09.11.2026
Weight-Loss Drugs May Help Sleep Apnea and Arthritis
time.com
09.11.2026
Related stories
U.S. government grounds all flights across the United States ‘due to extraordinary cirumstances’
FAA Grounds All US Flights Until Further Notice
Microsoft 'deeply sorry' for global outage after almost 24 hours of disruption
This young startup wants to power floating data centers with the ocean’s heat, and investors are already on board
In elephants, the resilience of communities has its limits
Trump Jr. out as Kalshi advisor after his firm's big investment in Polymarket